Company intelligence / Profile preview

Mithrl

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Mithrl is a biotechnology company that utilizes artificial intelligence to design and engineer next-generation biologics. The company's platform integrates generative machine learning models with high-throughput laboratory experiments to create novel proteins and antibodies with optimized therapeutic properties. By focusing on de novo design rather than traditional screening, Mithrl aims to accelerate the development of treatments for challenging diseases. Headquartered in San Francisco, the company is backed by leading venture capital firms including Andreessen Horowitz.

Modalities: AntibodyMonoclonal antibodyProtein
Industry: Biotech

Beyond the preview

Go deeper on Mithrl.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mithrl.

Explore the full profile